We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
View Top Employees from Menlo Therapeutics Inc.| Website | http://www.menlotherapeutics.com |
| Ticker | MNLO |
| Revenue | $10 million |
| Funding | $196.2 million |
| Employees | 5 (5 on RocketReach) |
| Founded | 2015 |
| Address | 200 Cardinal Way Suite 2B, Redwood City, California 94063, US |
| Phone | (650) 486-1416 |
| Technologies |
JavaScript,
HTML,
PHP
+15 more
(view full list)
|
| Industry | Education, Pharmaceutical Manufacturing, Organizations, Health Care, Drug Discovery, Pharmaceutical, Pharmaceuticals, Therapeutics |
| Competitors | AnaMar Medical AB, Aurinia Pharmaceuticals Inc., Cavion, Inc., Retrotope, Inc., Rexahn Pharmaceuticals |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Menlo Therapeutics Inc. employee's phone or email?
Menlo Therapeutics Inc. Questions
The Menlo Therapeutics Inc. annual revenue was $10 million in 2024.
5 people are employed at Menlo Therapeutics Inc..
Menlo Therapeutics Inc. is based in Redwood City, California.
The NAICS codes for Menlo Therapeutics Inc. are [541, 32541, 3254, 325, 32, 54, 5417].
The SIC codes for Menlo Therapeutics Inc. are [873, 87].
Top Menlo Therapeutics Inc. Employees
-
ViewAnna Gururajan
Clinical Operations at Menlo Therapeutics Inc.
Redwood City, California, United States -
ViewMaryam Headd
Senior Clinical Scientist at Menlo Therapeutics Inc.
San Francisco, California, United States1
Related Companies
